Compliance Rate

Compliance Rate 100.0%
Compliant submissions 1
Incompliant submissions 0
Total trials 1

My Organizations' Clinical Trials

Showing 1525 of 2228 entries
View as:

Phase I/II Comparison of Efficacy and Safety of BIBF 1120 and Sorafenib in Patients With Advanced Hepatocellular Carcinoma

Phase: N/A Priority: Normal
NCT ID: NCT01004003 Org: User:
Start: 10/22/09 End: 10/12/16 Due: 10/12/17

BI 894999 First in Human Dose Finding Study in Advanced Malignancies

Phase: N/A Priority: Normal
NCT ID: NCT02516553 Org: User:
Start: 07/08/15 End: 11/23/21 Due: 11/23/22

Telmisartan80/HCTZ25 Versus Telmisartan80/HCTZ12.5 in Hypertension Not Responding to Telmisartan80/HCTZ12.5

Phase: N/A Priority: Normal
NCT ID: NCT00239369 Org: User:
Start: 10/31/05 End: 08/31/06 Due: 08/31/07

Efficacy and Safety of Pramipexole Compared to Placebo in the Treatment of Restless Legs Syndrome (RLS)

Phase: N/A Priority: Normal
NCT ID: NCT00133198 Org: User:
Start: 04/30/04 End: 02/28/05 Due: 02/28/06

Bioequivalence of Telmisartan/ HCTZ Fixed Dose Combination Compared With Its Monocomponents in Healthy Male Volunteers II

Phase: N/A Priority: Normal
NCT ID: NCT02262858 Org: User:
Start: 08/31/05 End: - Due: -

Pharmacokinetic (PK) Assessment of BIBR 1048 in Patients After Primary Elective Total Hip Replacement Surgery

Phase: N/A Priority: Normal
NCT ID: NCT02170935 Org: User:
Start: 04/30/02 End: - Due: -

A Study in Healthy Men to Find the Best Formulation of BI 894416 and to Test How This is Taken up in the Body

Phase: N/A Priority: Normal
NCT ID: NCT04232839 Org: User:
Start: 02/25/20 End: 11/30/20 Due: 11/30/21

Relative Bioavailability of Dabigatran Etexilate Capsules With and Without Quinidine Sulfate Tablets and to Measure the Effect of Quinidine on the Absorption of Fexofenadine in Healthy Male and Female Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT02171546 Org: User:
Start: 11/30/07 End: - Due: -

A Study to Test Whether Vicadrostat in Combination With Empagliflozin Helps People With Chronic Kidney Disease

Phase: N/A Priority: Normal
NCT ID: NCT06926660 Org: User:
Start: 06/16/25 End: 01/08/27 Due: 01/08/28

A Study to Test Different Doses of BI 836880 Combined With Ezabenlimab in Patients With Advanced Non-small Cell Lung Cancer Followed by Other Types of Advanced Solid Tumours

Phase: N/A Priority: Normal
NCT ID: NCT03468426 Org: User:
Start: 07/05/18 End: 09/12/24 Due: 09/12/25

Effect of Tiotropium Plus Salmeterol vs. Fluticasone/Salmeterol on Static Lung Volumes and Exercise Endurance in COPD

Phase: N/A Priority: Normal
NCT ID: NCT00530842 Org: User:
Start: 09/30/07 End: - Due: -

Effect of BIBW 2948 BS in COPD

Phase: N/A Priority: Normal
NCT ID: NCT00423137 Org: User:
Start: 01/17/07 End: 07/09/08 Due: 07/09/09

Postmarketing Surveillance Study With MOBEC®

Phase: N/A Priority: Normal
NCT ID: NCT02182726 Org: User:
Start: 05/31/01 End: - Due: -

Weekly BI 836880 in Patients With Advanced Solid Tumors

Phase: N/A Priority: Normal
NCT ID: NCT02689505 Org: User:
Start: 04/04/16 End: 07/31/19 Due: 07/31/20

Evaluation of Efficacy and Safety of Meloxicam Suppository (15mg Daily) and Tablet (15 mg Daily) Compared to Indomethacin Suppository (50 mg Daily) in Patients With Ankylosing Spondylitis

Phase: N/A Priority: Normal
NCT ID: NCT02183168 Org: User:
Start: 07/01/01 End: - Due: -

A Multi-Center, Placebo-Controlled, Double-Blind, Randomized Trial Comparing the Virologic and Immunologic Activities of 400 Mg Nevirapine in Combination With Zidovudine Versus Zidovudine Alone in Asymptomatic HIV-1 Infected Patients With 4-12 Months of Prior Zidovudine Therapy and 200-500 CD4+ Cell

Phase: N/A Priority: Normal
NCT ID: NCT00002323 Org: User:
Start: - End: - Due: -

A Study in Healthy Men to Test Whether BI 409306, BI 425809 or Lamotrigine Can Reverse the Memory Problems Caused by Ketamine

Phase: N/A Priority: Normal
NCT ID: NCT04602221 Org: User:
Start: 12/01/20 End: 08/12/22 Due: 08/12/23

Relative Bioavailability of a Single-dose Administration of BIBW 2992 and Multiple-dose Administration of Ritonavir in Healthy Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT02171754 Org: User:
Start: 09/30/09 End: - Due: -

Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of BI 1356 BS as Tablet in Patients With Type 2 Diabetes

Phase: N/A Priority: Normal
NCT ID: NCT02183415 Org: User:
Start: 08/31/05 End: - Due: -

Pharmacokinetics of Talsaclidine After Administration to Healthy Subjects

Phase: N/A Priority: Normal
NCT ID: NCT02264054 Org: User:
Start: 02/28/99 End: - Due: -

A Study to Test BI 754091 Alone or in Combination With BI 836880 in People Who Have Advanced Anal Cancer

Phase: N/A Priority: Normal
NCT ID: NCT04499352 Org: User:
Start: 09/14/20 End: 10/19/20 Due: 10/19/21

Influence of Pantoprazole on the Pharmacokinetics of Fradafiban After Multiple Oral Doses of Lefradafiban Over 5 Days in Healthy Subjects

Phase: N/A Priority: Normal
NCT ID: NCT02264106 Org: User:
Start: 04/30/98 End: - Due: -

Multiple Rising Inhalative Doses of BI 1744 CL in Healthy Male Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT02172105 Org: User:
Start: 01/31/08 End: - Due: -

The Safety and Effectiveness of Warfarin and Dabigatran Prescribed in the Non-Valvular Atrial Fibrillation Population With DoD Healthcare Coverage

Phase: N/A Priority: Normal
NCT ID: NCT02043808 Org: User:
Start: 01/31/14 End: 05/31/14 Due: 05/31/15

Comparing the Efficacy of Tiotropium + Olodaterol (5/5 µg) Fixed Dose Combination (FDC) Over Tiotropium 5µg in Reducing Moderate to Severe Exacerbations in Patients With Severe to Very Severe Chronic Obstructive Pulmonary Disease.

Phase: N/A Priority: Normal
NCT ID: NCT02296138 Org: User:
Start: 01/13/15 End: 03/29/17 Due: 03/29/18